DA Ahlquist, HS Wieand, CG Moertel, DB … - Jama, 1993 - Am Med Assoc OBJECTIVES--To define the validity of fecal blood as a marker for colorectal
neoplasia in the screening setting and to compare yields by Hemoccult and
HemoQuant fecal occult blood screening tests. DESIGN--A multicenter masked ... Cited by 295 - Related articles - BL Direct - All 6 versions
- ►bmj.com J Tibble, G Sigthorsson, R Foster, R Sherwood … - British Medical Journal, 2001 - gut.bmj.com Colorectal cancer is the second commonest cause of death from malignancy in the
Western world. In the USA it accounts for 14% of cancer deaths with about 134
000 colorectal cancer registrations and 55 000 deaths each year 1 while in ... Cited by 64 - Related articles - BL Direct - All 7 versions
PD Greenberg, JP Cello, DC Rockey - The American journal of medicine, 1996 - Elsevier Patients taking no aspirin had mean fecal blood of 0.68 ± 0.05 mg hemoglobin/g
stool, which increased to 1.41 ± 0.36 mg/g after taking 325 mg of aspirin daily
(P = 0.02). In contrast, patients in group 2, taking 81 mg and 325 mg of ... Cited by 49 - Related articles - All 7 versions
- ►cancer.org [PDF] JF Helm, RS Sandler - Medical Clinics of North America, 1999 - Elsevier Evidence indicates that detection of colorectal cancer at an early asymptomatic
stage by screening can improve survival (secondary prevention). 23 , 33 and 42
The estimated 5-year survival from colorectal cancer is about 90% in those ... Cited by 31 - Related articles - BL Direct - All 23 versions
J Van Dam, JH Bond, MV Sivak Jr - Archives of Internal Medicine, 1995 - archinte.highwire.org Colorectal cancer is currentlysecond on the list ofcommon cancers affectingboth
men and women in the United States. In the ab¬ sence of any form of
intervention, the risk of developing colorectal cancer for an in¬ dividual ... Cited by 28 - Related articles - BL Direct - All 4 versions
M Nakajima, H Saito, Y Soma, T Sobue, M … - British journal of cancer, 2003 - pubmedcentral.nih.gov Colorectal cancer is one of the highest causes of cancer deaths in many
countries (Schottenfeld and Winawer, 1996). Accordingly, prevention is an issue
of global importance. Although colorectal cancer is considered to be ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►72.167.87.44 [PDF] ML Borum - Primary Care: Clinics in Office Practice, 2001 - Elsevier All individuals with a history of adenomas are at risk for development of
additional adenomas. Individuals with previous adenomas can be categorized into
different risk groups, however, depending upon the histologic type and ... Cited by 18 - Related articles - BL Direct - All 4 versions
JM Ferrante - Medical Clinics of North America, 1996 - Elsevier Colorectal cancer is the second most common cause of death from cancer in the
United States. It ranks third to lung and prostate cancers in men and third to
lung and breast cancers in women. In 1995, it was predicted there would be ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►annals.org DF Ransohoff, CA Lang - Annals of Internal Medicine, 1997 - Am Coll Physicians Purpose: Screening for colorectal cancer with fecal occult blood tests or
sigmoidoscopy can reduce mortality rates. If occult blood testing is done,
clinicians must decide how to interpret the results and plan further ... Cited by 14 - Related articles - All 3 versions
H Nakama, N Kamijo, K Fujimori, ASMA … - Diseases of the Colon & Rectum, 1997 - Springer PURPOSE: The present study was conducted to assess the accuracy of three testing
methods using an immunochemi- cal fecal occult blood test based on the number of
samples as the optimum means for screening of colorectal cancer. METHOD: ... Cited by 12 - Related articles - All 4 versions
